Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
37 participants
INTERVENTIONAL
2012-08-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise
NCT02032628
The Effect of Exercise on Myokine Production in Aging Persons
NCT05571709
High Intensity and Moderate Training and Maximal Oxygen Uptake and Activity Levels
NCT01931124
The Effects of High-Intensity Exercise on Biological Age
NCT05156918
Gene - Exercise Research Study
NCT00976742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-intensity interval training
The High-intensity interval training group was instructed to complete exercise sessions of 4x4-minutes intervals at 85-95% of maximal heart rate, 3 times a week for 8 weeks. This type of exercise include 10 minutes warm-up, followed by four intervals of four minutes high-intensity (85-95% of HRmax), with three minutes active breaks (70% of HRmax) between each interval, and ending with seven minutes cool-down. An exercise session last for 42 minutes, where the participants should breathe heavily and feel exhausted four times.
High-intensity interval training
Interval training 3 times a week for 8 weeks
Moderate training
The moderate training group was instructed to complete exercise sessions of 50 minutes at 70% of maximal heart rate, 3 times a week for 8 weeks.
Moderate training
Moderate training 3 times a week for 8 weeks
Control
The control group followed the baseline and follow-up tests, and was asked to live normally and not change their dietary pattern or exercise habits during their participation in this project. Based on the well-known beneficial effects of exercise on general health, it was regarded unethical to demand the control group to desist from any types of physical activity during the project period. They got no further follow-up on exercise.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-intensity interval training
Interval training 3 times a week for 8 weeks
Moderate training
Moderate training 3 times a week for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 70-75 years old
* Signed written informed consent
Exclusion Criteria
* Known cardiac disease
* Active cancer
* Significant pulmonary disease
* Uncontrolled hypertension
* Use of blood thinning medicine (except Albyl-E)
* Drug abuse
* Alcohol abuse
* Finishing less than 80% of the exercise sessions (this complies to the training groups)
70 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrik Wisløff, Professor
Role: STUDY_DIRECTOR
National Taiwan Normal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Circulation and Medical Imaging, NTNU
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPI-GEN100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.